252 related articles for article (PubMed ID: 17393491)
1. Interactions between neural membrane glycerophospholipid and sphingolipid mediators: a recipe for neural cell survival or suicide.
Farooqui AA; Horrocks LA; Farooqui T
J Neurosci Res; 2007 Jul; 85(9):1834-50. PubMed ID: 17393491
[TBL] [Abstract][Full Text] [Related]
2. Comparison of biochemical effects of statins and fish oil in brain: the battle of the titans.
Farooqui AA; Ong WY; Horrocks LA; Chen P; Farooqui T
Brain Res Rev; 2007 Dec; 56(2):443-71. PubMed ID: 17959252
[TBL] [Abstract][Full Text] [Related]
3. Lipid mediators in the neural cell nucleus: their metabolism, signaling, and association with neurological disorders.
Farooqui AA
Neuroscientist; 2009 Aug; 15(4):392-407. PubMed ID: 19666894
[TBL] [Abstract][Full Text] [Related]
4. Lipid mediators and their metabolism in the nucleous: implications for Alzheimer's disease.
Farooqui AA
J Alzheimers Dis; 2012; 30 Suppl 2():S163-78. PubMed ID: 21955817
[TBL] [Abstract][Full Text] [Related]
5. Lipid mediators in the nucleus: Their potential contribution to Alzheimer's disease.
Farooqui AA; Ong WY; Farooqui T
Biochim Biophys Acta; 2010 Aug; 1801(8):906-16. PubMed ID: 20170745
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine 1-phosphate is a key metabolite linking sphingolipids to glycerophospholipids.
Kihara A
Biochim Biophys Acta; 2014 May; 1841(5):766-72. PubMed ID: 23994042
[TBL] [Abstract][Full Text] [Related]
7. Role of sphingolipids in arachidonic acid metabolism.
Nakamura H; Murayama T
J Pharmacol Sci; 2014; 124(3):307-12. PubMed ID: 24599139
[TBL] [Abstract][Full Text] [Related]
8. Deacylation and reacylation of neural membrane glycerophospholipids.
Farooqui AA; Horrocks LA; Farooqui T
J Mol Neurosci; 2000 Jun; 14(3):123-35. PubMed ID: 10984188
[TBL] [Abstract][Full Text] [Related]
9. Sphingolipids in mammalian cell signalling.
Ohanian J; Ohanian V
Cell Mol Life Sci; 2001 Dec; 58(14):2053-68. PubMed ID: 11814056
[TBL] [Abstract][Full Text] [Related]
10. Soluble oligomers of amyloid-beta peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway.
Malaplate-Armand C; Florent-Béchard S; Youssef I; Koziel V; Sponne I; Kriem B; Leininger-Muller B; Olivier JL; Oster T; Pillot T
Neurobiol Dis; 2006 Jul; 23(1):178-89. PubMed ID: 16626961
[TBL] [Abstract][Full Text] [Related]
11. Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders.
Farooqui AA; Horrocks LA; Farooqui T
Chem Phys Lipids; 2000 Jun; 106(1):1-29. PubMed ID: 10878232
[TBL] [Abstract][Full Text] [Related]
12. Sphingolipid metabolites in neural signalling and function.
Colombaioni L; Garcia-Gil M
Brain Res Brain Res Rev; 2004 Nov; 46(3):328-55. PubMed ID: 15571774
[TBL] [Abstract][Full Text] [Related]
13. Multifaceted roles of sphingosine-1-phosphate: how does this bioactive sphingolipid fit with acute neurological injury?
Singh IN; Hall ED
J Neurosci Res; 2008 May; 86(7):1419-33. PubMed ID: 18058948
[TBL] [Abstract][Full Text] [Related]
14. Stored platelets alter glycerophospholipid and sphingolipid species, which are differentially transferred to newly released extracellular vesicles.
Pienimaeki-Roemer A; Ruebsaamen K; Boettcher A; Orsó E; Scherer M; Liebisch G; Kilalic D; Ahrens N; Schmitz G
Transfusion; 2013 Mar; 53(3):612-26. PubMed ID: 22804622
[TBL] [Abstract][Full Text] [Related]
15. Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology.
Merrill AH; Schmelz EM; Dillehay DL; Spiegel S; Shayman JA; Schroeder JJ; Riley RT; Voss KA; Wang E
Toxicol Appl Pharmacol; 1997 Jan; 142(1):208-25. PubMed ID: 9007051
[TBL] [Abstract][Full Text] [Related]
16. Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathology.
Frisardi V; Panza F; Seripa D; Farooqui T; Farooqui AA
Prog Lipid Res; 2011 Oct; 50(4):313-30. PubMed ID: 21703303
[TBL] [Abstract][Full Text] [Related]
17. Sphingolipids in psychiatric disorders and pain syndromes.
Mühle C; Reichel M; Gulbins E; Kornhuber J
Handb Exp Pharmacol; 2013; (216):431-56. PubMed ID: 23563670
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the activity of cytosolic phospholipase A2alpha (cPLA2alpha) by cellular sphingolipids and inhibition of cPLA2alpha by sphingomyelin.
Nakamura H; Wakita S; Suganami A; Tamura Y; Hanada K; Murayama T
J Lipid Res; 2010 Apr; 51(4):720-8. PubMed ID: 19965591
[TBL] [Abstract][Full Text] [Related]
19. Role of sphingomyelinases in neurological disorders.
Ong WY; Herr DR; Farooqui T; Ling EA; Farooqui AA
Expert Opin Ther Targets; 2015; 19(12):1725-42. PubMed ID: 26243307
[TBL] [Abstract][Full Text] [Related]
20. Sphingolipid metabolizing enzymes as novel therapeutic targets.
Billich A; Baumruker T
Subcell Biochem; 2008; 49():487-522. PubMed ID: 18751924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
